Paper14435563
Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects.
QUINN GP and 2 others. J Pharmacol Exp Ther, 1959. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. Papers, record 14435563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14435563
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypnotics and Sedatives | Major topic |
| Reserpine | Major topic |
| Tetrabenazine | Major topic |
| Tranquilizing Agents | Major topic |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41452009 | Deciphering Ibogaine's Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/41452009 | PubMed |
| 39618418 | How antipsychotics work in schizophrenia: a primer on mechanisms. | CNS Spectr | 2024 | https://conductscience.org/library/papers/39618418 | PubMed |
| 36120044 | Stereoselective Synthesis of Benzo[a]quinolizidines via Aerobic DDQ-Catalyzed Allylation and Reductive Cyclization. | ACS Omega | 2022 | https://conductscience.org/library/papers/36120044 | PubMed |
| 30237454 | Therapeutic approaches to Huntington disease: from the bench to the clinic. | Nat Rev Drug Discov | 2018 | https://conductscience.org/library/papers/30237454 | PubMed |
| 28782244 | Using the affective bias test to predict drug-induced negative affect: implications for drug safety. | Br J Pharmacol | 2017 | https://conductscience.org/library/papers/28782244 | PubMed |
| 26000211 | Effect of tetrabenazine on motor function in patients with huntington disease. | Neurol Ther | 2012 | https://conductscience.org/library/papers/26000211 | PubMed |
| 22778401 | Brain dopamine and serotonin differ in regulation and its consequences. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22778401 | PubMed |
| 22133328 | Tetrabenazine: for chorea associated with Huntington's disease. | CNS Drugs | 2011 | https://conductscience.org/library/papers/22133328 | PubMed |
| 20135628 | Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry. | Med Res Rev | 2011 | https://conductscience.org/library/papers/20135628 | PubMed |
| 19381278 | Tetrabenazine in the treatment of Huntington's disease. | Neuropsychiatr Dis Treat | 2007 | https://conductscience.org/library/papers/19381278 | PubMed |
| 19116624 | Tetrabenazine. | Nat Rev Drug Discov | 2009 | https://conductscience.org/library/papers/19116624 | PubMed |
| 18544005 | Tourette's syndrome and role of tetrabenazine: review and personal experience. | Clin Drug Investig | 2008 | https://conductscience.org/library/papers/18544005 | PubMed |
| 14482990 | The inactivation of 5-hydroxytryptamine by blood platelets in mental deficiency with elevated serum 5-hydroxytryptamine. | Psychopharmacologia | 1962 | https://conductscience.org/library/papers/14482990 | PubMed |
| 14429629 | Inhibition of 5-hydroxytryptamine release from blood platelets by N2-isopropyl isonicotinic acid hydrazide. | Experientia | 1960 | https://conductscience.org/library/papers/14429629 | PubMed |
| 14429628 | Increase of free 5-hydroxytryptamine in blood plasma by reserpine and a benzoquinolizine derivative. | Experientia | 1959 | https://conductscience.org/library/papers/14429628 | PubMed |
| 14230236 | ON THE MECHANISM OF ACTION OF CHLORPROMAZINE IN RELEASING 5-HYDROXYTRYPTAMINE FROM BLOOD PLATELETS IN VITRO. | Naunyn Schmiedebergs Arch Exp Pathol Pharmakol | 1964 | https://conductscience.org/library/papers/14230236 | PubMed |
| 14151552 | ENHANCED DEPRESSANT EFFECT OF TETRABENAZINE AFTER REPEATED ADMINISTRATION. | Psychopharmacologia | 1964 | https://conductscience.org/library/papers/14151552 | PubMed |
| 14066151 | THE INCREASE IN THE TOXICITY OF YOHIMBINE INDUCED BY IMIPRAMINE AND OTHER DRUGS IN MICE. | Br J Pharmacol Chemother | 1963 | https://conductscience.org/library/papers/14066151 | PubMed |
| 13889332 | [Inhibitory effect of tetrabenazine on the adrenal cortex-influencing action of reserpine]. | Experientia | 1962 | https://conductscience.org/library/papers/13889332 | PubMed |
| 6310099 | Reserpine has a direct action as a calcium antagonist on mammalian smooth muscle cells. | J Physiol | 1983 | https://conductscience.org/library/papers/6310099 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14435563
GET https://conductscience.org/api/papers/v1/14435563/cited_by?page=2